Cargando…

Impaired plasma phospholipids and relative amounts of essential polyunsaturated fatty acids in autistic patients from Saudi Arabia

BACKGROUNDS: Autism is a developmental disorder characterized by social and emotional deficits, language impairments and stereotyped behaviors that manifest in early postnatal life. This study aims to compare the relative concentrations of essential fatty acids (Linoleic and α- linolenic), their lon...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Ansary, Afaf K, Ben Bacha, Abir G, Al- Ayahdi, Layla Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3107801/
https://www.ncbi.nlm.nih.gov/pubmed/21513514
http://dx.doi.org/10.1186/1476-511X-10-63
_version_ 1782205249887404032
author El-Ansary, Afaf K
Ben Bacha, Abir G
Al- Ayahdi, Layla Y
author_facet El-Ansary, Afaf K
Ben Bacha, Abir G
Al- Ayahdi, Layla Y
author_sort El-Ansary, Afaf K
collection PubMed
description BACKGROUNDS: Autism is a developmental disorder characterized by social and emotional deficits, language impairments and stereotyped behaviors that manifest in early postnatal life. This study aims to compare the relative concentrations of essential fatty acids (Linoleic and α- linolenic), their long chain polyunsaturated fatty acids and phospholipids in plasma of autistic patients from Saudi Arabia with age-matching controls. METHODS: 25 autistic children aged 3-15 years and 16 healthy children as control group were included in this study. Relative concentration of essential fatty acids/long chain polyunsaturated fatty acids and omega-3/omega-6 fatty acid series together with phosphatidylethanolamine, phosphatidylserine and phosphatidylcholine were measured in plasma of both groups. RESULTS: Remarkable alteration of essential fatty acids/long chain polyunsaturated fatty acids, omeg-3/omega-6 and significant lower levels of phospholipids were reported. Reciever Operating characteristics (ROC) analysis of the measured parameters revealed a satisfactory level of sensitivity and specificity. CONCLUSION: Essential fatty acids/long chain polyunsaturated fatty acids and omeg-3/omega-6 ratios, phosphatidylethanolamine, phosphatidylserine and phosphatidylcholine could be used as potential biomarkers that point to specific mechanisms in the development of autism and may help tailor treatment or prevention strategies.
format Online
Article
Text
id pubmed-3107801
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31078012011-06-04 Impaired plasma phospholipids and relative amounts of essential polyunsaturated fatty acids in autistic patients from Saudi Arabia El-Ansary, Afaf K Ben Bacha, Abir G Al- Ayahdi, Layla Y Lipids Health Dis Research BACKGROUNDS: Autism is a developmental disorder characterized by social and emotional deficits, language impairments and stereotyped behaviors that manifest in early postnatal life. This study aims to compare the relative concentrations of essential fatty acids (Linoleic and α- linolenic), their long chain polyunsaturated fatty acids and phospholipids in plasma of autistic patients from Saudi Arabia with age-matching controls. METHODS: 25 autistic children aged 3-15 years and 16 healthy children as control group were included in this study. Relative concentration of essential fatty acids/long chain polyunsaturated fatty acids and omega-3/omega-6 fatty acid series together with phosphatidylethanolamine, phosphatidylserine and phosphatidylcholine were measured in plasma of both groups. RESULTS: Remarkable alteration of essential fatty acids/long chain polyunsaturated fatty acids, omeg-3/omega-6 and significant lower levels of phospholipids were reported. Reciever Operating characteristics (ROC) analysis of the measured parameters revealed a satisfactory level of sensitivity and specificity. CONCLUSION: Essential fatty acids/long chain polyunsaturated fatty acids and omeg-3/omega-6 ratios, phosphatidylethanolamine, phosphatidylserine and phosphatidylcholine could be used as potential biomarkers that point to specific mechanisms in the development of autism and may help tailor treatment or prevention strategies. BioMed Central 2011-04-22 /pmc/articles/PMC3107801/ /pubmed/21513514 http://dx.doi.org/10.1186/1476-511X-10-63 Text en Copyright ©2011 El-Ansary et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
El-Ansary, Afaf K
Ben Bacha, Abir G
Al- Ayahdi, Layla Y
Impaired plasma phospholipids and relative amounts of essential polyunsaturated fatty acids in autistic patients from Saudi Arabia
title Impaired plasma phospholipids and relative amounts of essential polyunsaturated fatty acids in autistic patients from Saudi Arabia
title_full Impaired plasma phospholipids and relative amounts of essential polyunsaturated fatty acids in autistic patients from Saudi Arabia
title_fullStr Impaired plasma phospholipids and relative amounts of essential polyunsaturated fatty acids in autistic patients from Saudi Arabia
title_full_unstemmed Impaired plasma phospholipids and relative amounts of essential polyunsaturated fatty acids in autistic patients from Saudi Arabia
title_short Impaired plasma phospholipids and relative amounts of essential polyunsaturated fatty acids in autistic patients from Saudi Arabia
title_sort impaired plasma phospholipids and relative amounts of essential polyunsaturated fatty acids in autistic patients from saudi arabia
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3107801/
https://www.ncbi.nlm.nih.gov/pubmed/21513514
http://dx.doi.org/10.1186/1476-511X-10-63
work_keys_str_mv AT elansaryafafk impairedplasmaphospholipidsandrelativeamountsofessentialpolyunsaturatedfattyacidsinautisticpatientsfromsaudiarabia
AT benbachaabirg impairedplasmaphospholipidsandrelativeamountsofessentialpolyunsaturatedfattyacidsinautisticpatientsfromsaudiarabia
AT alayahdilaylay impairedplasmaphospholipidsandrelativeamountsofessentialpolyunsaturatedfattyacidsinautisticpatientsfromsaudiarabia